PL2925347T3 - Roztwór trombiny i sposoby jego zastosowania - Google Patents

Roztwór trombiny i sposoby jego zastosowania

Info

Publication number
PL2925347T3
PL2925347T3 PL13820993T PL13820993T PL2925347T3 PL 2925347 T3 PL2925347 T3 PL 2925347T3 PL 13820993 T PL13820993 T PL 13820993T PL 13820993 T PL13820993 T PL 13820993T PL 2925347 T3 PL2925347 T3 PL 2925347T3
Authority
PL
Poland
Prior art keywords
methods
thrombin solution
thrombin
solution
Prior art date
Application number
PL13820993T
Other languages
English (en)
Inventor
Roberto Meidler
Oleg BELYAEV
Liliana Bar
Israel Nur
Original Assignee
Omrix Biopharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omrix Biopharmaceuticals Ltd. filed Critical Omrix Biopharmaceuticals Ltd.
Publication of PL2925347T3 publication Critical patent/PL2925347T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6429Thrombin (3.4.21.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26DRYING
    • F26BDRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
PL13820993T 2012-12-03 2013-11-28 Roztwór trombiny i sposoby jego zastosowania PL2925347T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL22339612 2012-12-03
US201361753542P 2013-01-17 2013-01-17
EP13820993.7A EP2925347B1 (en) 2012-12-03 2013-11-28 Thrombin solution and methods of use thereof
PCT/IL2013/000088 WO2014087394A1 (en) 2012-12-03 2013-11-28 Thrombin solution and methods of use thereof

Publications (1)

Publication Number Publication Date
PL2925347T3 true PL2925347T3 (pl) 2020-12-28

Family

ID=50825810

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13820993T PL2925347T3 (pl) 2012-12-03 2013-11-28 Roztwór trombiny i sposoby jego zastosowania

Country Status (13)

Country Link
US (5) US9212357B2 (pl)
EP (2) EP3760221A1 (pl)
JP (2) JP6526565B2 (pl)
KR (1) KR102101611B1 (pl)
CN (2) CN104822387A (pl)
AU (1) AU2013353636B2 (pl)
BR (2) BR122022012099B1 (pl)
CA (1) CA2892083A1 (pl)
IL (1) IL239043B (pl)
MX (1) MX358132B (pl)
PL (1) PL2925347T3 (pl)
RU (1) RU2670956C9 (pl)
WO (1) WO2014087394A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9212357B2 (en) 2012-12-03 2015-12-15 Omrix Biopharmaceuticals Ltd. Thrombin solution and methods of use thereof
WO2016146043A1 (en) * 2015-03-13 2016-09-22 Chung Chin Sun Method of stabilizing thrombin and composition thereof
IL242984A0 (en) * 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
US10159720B2 (en) 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
US10420134B2 (en) 2016-02-02 2019-09-17 Cisco Technology, Inc. System and method to facilitate subframe scheduling in a split medium access control radio access network environment
CN109010906B (zh) * 2018-08-16 2021-05-14 陈明远 一种促进术后伤口局部止血及促进术后创面上皮化的生物胶水及其工作方法
IL263679A (en) * 2018-12-12 2019-03-31 Omrix Biopharmaceuticals Ltd Kits, methods, and compositions for preventing tissue adhesion

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63243032A (ja) * 1987-03-27 1988-10-07 Green Cross Corp:The トロンビンの加熱処理方法
US5605884A (en) 1987-10-29 1997-02-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Factor VIII formulations in high ionic strength media
US4877608A (en) 1987-11-09 1989-10-31 Rorer Pharmaceutical Corporation Pharmaceutical plasma protein formulations in low ionic strength media
JP2715104B2 (ja) * 1988-08-18 1998-02-18 株式会社ミドリ十字 トロンビン乾燥製剤
DE3843126C3 (de) 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
EP1016673B1 (en) 1992-10-02 2006-02-01 Genetics Institute, LLC Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer
CN1100655A (zh) * 1992-11-19 1995-03-29 迟斌元 一种含有缓冲剂和凝血酶的药物组合物
JP3028274B2 (ja) * 1994-09-30 2000-04-04 持田製薬株式会社 トロンビン固形製剤の安定化方法
GB9503750D0 (en) 1995-02-24 1995-04-12 Common Services Agency Thrombin preparation
JPWO2004043503A1 (ja) * 2002-11-14 2006-03-09 財団法人化学及血清療法研究所 トロンビン固定化生体吸収性合成不織布
ES2313383T3 (es) * 2004-06-22 2009-03-01 Zymogenetics, Inc. Composiciones de trombina.
EP1927658B1 (en) 2004-06-22 2012-10-10 Zymogenetics, Inc. Thrombin compositions
ES2226587B1 (es) * 2004-10-22 2005-12-16 Probitas Pharma, S.A. Composicion de trombina estable.
ES2390354T3 (es) * 2005-07-22 2012-11-12 Amgen, Inc Liofilizados de proteínas concentrados, procedimientos y usos
WO2007029159A1 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited A process for the preparation of lyophilized sodium bicarbonate
EA018440B1 (ru) 2006-11-24 2013-08-30 Кадила Хелзкэр Лимитед Композиции конъюгатов пэг-интерферон альфа
US9017664B2 (en) * 2006-12-15 2015-04-28 Lifebond Ltd. Gelatin-transglutaminase hemostatic dressings and sealants
CN101214374A (zh) * 2007-01-05 2008-07-09 兆科药业(合肥)有限公司 具有促凝血与止血功能的制剂
WO2009109963A1 (en) 2008-03-03 2009-09-11 Omrix Biopharmaceuticals Ltd. A gelatin sponge comprising an active ingredient, its preparation and use
US10039865B2 (en) * 2008-09-22 2018-08-07 Omrix Biopharmaceuticals Ltd. Implantable device comprising a substrate pre-coated with stabilized fibrin
ES2706296T3 (es) 2008-11-07 2019-03-28 Univ Connecticut Formulaciones de Factor VIII
WO2011131720A1 (en) 2010-04-20 2011-10-27 Octapharma Ag New stabilizing agent for pharmaceutical proteins
MX352875B (es) * 2010-06-01 2017-12-13 Baxter Healthcare Sa Proceso para elaborar composiciones hemostaticas secas y estables.
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
US9212357B2 (en) 2012-12-03 2015-12-15 Omrix Biopharmaceuticals Ltd. Thrombin solution and methods of use thereof

Also Published As

Publication number Publication date
JP6526565B2 (ja) 2019-06-05
US11993797B2 (en) 2024-05-28
EP2925347A1 (en) 2015-10-07
HK1214958A1 (en) 2016-08-12
AU2013353636B2 (en) 2018-03-01
RU2670956C9 (ru) 2018-11-21
US10479987B2 (en) 2019-11-19
EP2925347B1 (en) 2020-08-26
MX358132B (es) 2018-08-06
IL239043B (en) 2020-09-30
KR102101611B1 (ko) 2020-04-20
RU2670956C2 (ru) 2018-10-26
JP2018162254A (ja) 2018-10-18
AU2013353636A1 (en) 2015-07-16
EP3760221A1 (en) 2021-01-06
IL239043A0 (en) 2015-07-30
US20200032239A1 (en) 2020-01-30
US20220098570A1 (en) 2022-03-31
CN110251468A (zh) 2019-09-20
KR20150091503A (ko) 2015-08-11
US11225652B2 (en) 2022-01-18
BR112015013071A2 (pt) 2017-07-11
US9212357B2 (en) 2015-12-15
US20140154773A1 (en) 2014-06-05
BR112015013071A8 (pt) 2019-10-08
BR112015013071B1 (pt) 2023-01-17
CA2892083A1 (en) 2014-06-12
US20240376459A1 (en) 2024-11-14
BR122022012099B1 (pt) 2023-01-24
WO2014087394A1 (en) 2014-06-12
MX2015006986A (es) 2015-09-23
CN104822387A (zh) 2015-08-05
US20160060614A1 (en) 2016-03-03
JP2016505543A (ja) 2016-02-25
RU2015126540A (ru) 2017-01-13

Similar Documents

Publication Publication Date Title
SG10201609940RA (en) Compounds and their methods of use
ZA201502503B (en) Hppd variants and methods of use
IL239353B (en) Continuous production unit and methods for using it
SI2909204T1 (sl) Inhibitorji GSK3 in postopki njihove uporabe
ZA201405858B (en) Recombinant microorganisms and methods of use thereof
EP2928384A4 (en) ANCHORS CAPTURED BY THE FABRIC AND METHOD OF USE
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
EP2790709A4 (en) HEMOSTATIC ACTIVE SUBSTANCES AND METHOD OF USE THEREOF
SG11201400567QA (en) Cd40l-specific tn3-derived scaffolds and methods of use thereof
EP2806811A4 (en) VERTEBRAL CONSTRUCTION
IL233481A0 (en) Peptides and methods of using them
ZA201406082B (en) Use of ccr3-inhibitors
IL239043A0 (en) Thrombin solution and methods of using it
ZA201405829B (en) Cleaning arrangement and method of use
PL2864417T3 (pl) Polimer i sposób zastosowania
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
ZA201405644B (en) Weatherised minerals and methods of making and using same
EP2859071A4 (en) CHEMICAL COMPOSITIONS AND METHODS OF USE
IL277033A (en) Thrombin solution and methods of using it
GB201416065D0 (en) Catalysts and methods of making and using catalysts